Profile for Zymeworks Inc. (ZYME)

$ 41.32   0.52 (+1.27%) Volume: 299.95k 4:00 PM EDT Oct 27, 2020
After Hours:  $ 41.3363   0.0163 (+0.04%) Volume: 182.5k 4:11 PM EDT Oct 27, 2020
Business Description:
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Address: 1385 West 8th Avenue, Suite 540, Vancouver, BC, CA, V6H 3V9
Telephone: +1 604 678-1388 Website: http://www.zymeworks.com
Facsimile: +1 604 737-7077 Email: [email protected]
Details
CEO: Ali Tehrani
Employees: 256 Market Cap: 1.62b
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1403752
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical and Medicine Industry (3741)